KCNMA1 and breast carcinoma: The pharmacological blockade and siRNA-mediated silencing of KCa1.1 induced cell-cycle arrest in the G0/G1 phase through the down-regulation of cyclin-D1 and cyclin-dependent kinase 4 (CDK4) [21,23] and attenuated breast cancer invasion and metastasis [24].